Business
Global Technologies, LTD Announces Strategic Pivot and New Agreements in Health & Wellness Sector
Greensboro, NC, June 04, 2025 (GLOBE NEWSWIRE) -- Global Technologies, LTD (OTCPK: GTLL), a public, multi-operational company focused on innovation in health and wellness, recently announced corporate developments and commercial milestones signaling a bold pivot in strategy and leadership. Over the past 90 days, GTLL has responded proactively to external FDA regulatory shifts that disrupted several industry sectors, including GLP-1 compounding and semaglutide supply. These changes catalyzed GTLL
About this update from Global Technologies, Ltd.
[{"type":"image","alt":"Global Technologies, Ltd","displaySize":"","headline":null,"caption":"Global Technologies, Ltd","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":103,"url":"https://media.zenfs.com/en/globenewswire.com/702dac63d672839a50295a742100f7e6"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/3ZIUBibOuygf1aO8JNyMcw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE0NDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/702dac63d672839a50295a742100f7e6","width":300,"height":103}},"lazy":false},{"type":"text","content":"Greensboro, NC, June 04, 2025 (GLOBE NEWSWIRE) -- Global Technologies, LTD (OTCPK: GTLL), a public, multi-operational company focused on innovation in health and wellness, recently announced corporate developments and commercial milestones signaling a bold pivot in strategy and leadership.","length":290,"tagName":"p"},{"type":"text","content":"Over the past 90 days, GTLL has responded proactively to external FDA regulatory shifts that disrupted several industry sectors, including GLP-1 compounding and semaglutide supply. These changes catalyzed GTLL’s sharpened focus on the digital health and wellness market, prompting operational streamlining and a commitment to scalable, revenue-focused platforms—particularly through its newly launched subsidiary, Primecare Supply, LLC.","length":436,"tagName":"p"},{"type":"text","content":"Launch of Primecare Supply and Execution of Key Agreements","length":58,"tagName":"p"},{"type":"text","content":"As disclosed in its May 30, 2025 Form 8-K filing, GTLL formally launched Primecare Supply, LLC and executed two transformative commercial agreements:","length":149,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"On May 19, 2025, Primecare entered into a Revenue Share Agreement with a licensed pharmaceutical supplier. Under this structure, Primecare retains 75% of gross margin revenue above the supplier’s floor price while supporting FDA-compliant sales and post-sale obligations to its network of wellness providers.","length":308,"tagName":"p"}]},{"val":[{"type":"text","content":"On May 28, 2025, Primecare signed a Master Licensing Agreement with a specialized AI technology partner, gaining access to tools for digital ordering, compliance automation, CRM management, and real-time operational analytics. The platform fee is 2.5% of processed tra...